Antihistamines improve cardiovascular manifestations and other symptoms of long-COVID attributed to mast cell activation
IntroductionLong-COVID is a broadly defined condition and there are no effective therapies. Cardiovascular manifestations of long-COVID include high heart rate, postural tachycardia, and palpitations. Previous studies have suggested that mast cell activation (MCA) may play a role in the pathophysiol...
Main Authors: | Fabrizio Salvucci, Roberto Codella, Adriana Coppola, Irene Zacchei, Gabriella Grassi, Maria Luisa Anti, Nicolita Nitisoara, Livio Luzi, Carmine Gazzaruso |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1202696/full |
Similar Items
-
The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets
by: Elden Berla Thangam, et al.
Published: (2018-08-01) -
Use of antihistamines in a physician's clinical practice
by: L V Luss
Published: (2014-08-01) -
Antihistamines Potentiate Dexamethasone Anti-Inflammatory Effects. Impact on Glucocorticoid Receptor-Mediated Expression of Inflammation-Related Genes
by: Carlos Daniel Zappia, et al.
Published: (2021-11-01) -
CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria
by: Michael N. Fein, et al.
Published: (2019-10-01) -
Actual antihistamine therapy
by: D. V. Shabanov, et al.
Published: (2020-11-01)